Skip to main content
. Author manuscript; available in PMC: 2023 May 17.
Published in final edited form as: J Alzheimers Dis. 2020;75(3):993–1002. doi: 10.3233/JAD-200252

Fig. 1.

Fig. 1.

Cognitive status of MCI patients on cholinesterase and add-on ω-3 therapies over the whole study. Note protection (months) of initial MMSE status in MCI patients: 43 (pt. #12), 41 (pt. #14), 23 (pt. #19), 20 (pt #28), and 11 (pt #33).